We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Alliance to Improve Detection of Cancer

By HospiMedica staff writers
Posted on 01 Nov 2000
Print article
In a strategic alliance aimed at improving the detection of cancer, Eastman Kodak Company (Rochester, NY, USA) plans to integrate computer aided detection (CAD ) software from R2 Technology (Los Altos, CA, USA) into its computed radiography (CR) and digital radiography (DR) systems.

R2 Technology uses pattern recognition algorithms to mark areas with subtle characteristics of specific disease states so radiologists can study those areas in greater detail, thereby enabling them to identify early-stage cancers. The company's ImageChecker System is based on this technology and is the only CAD system to be cleared by the U.S. Food and Drug Administration (FDA) for breast cancer screening. For every 1,000 cancers currently detected by mammography, R2 Technology reports that use of the ImageChecker could result in early detection of an additional 20,500 breast cancers.

Kodak and R2 Technology will work together to develop new applications for CAD technology in conjunction with a variety of imaging modalities. One field of interest is lung cancer, where currently only about 15% of cancers are found in the early stages because the disease is difficult to detect then. In the United States alone, an estimated 156,900 people will die of the disease in the year 2000.
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ambulatory Blood Pressure Monitor
ASPEL 308-508 ABPM
New
Endoscopic Surgical Medical Monitor
E2421

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more